Affiance Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
1,405
0.24% 42
2026
Q1
$1.29M Hold
1,405
0.21% 47
2025
Q4
$1.51M Sell
1,405
-116
-8% -$111K 0.24% 43
2025
Q3
$1.16M Sell
1,521
-115
-7% -$85.6K 0.21% 47
2025
Q2
$1.28M Sell
1,636
-11
-0.7% -$8.55K 0.26% 44
2025
Q1
$1.36M Sell
1,647
-6
-0.4% -$4.99K 0.32% 42
2024
Q4
$1.28M Sell
1,653
-272
-14% -$225K 0.31% 46
2024
Q3
$1.71M Hold
1,925
0.41% 37
2024
Q2
$1.74M Buy
1,925
+85
+5% +$68K 0.45% 34
2024
Q1
$1.43M Buy
1,840
+5
+0.3% +$3.56K 0.39% 38
2023
Q4
$1.07M Hold
1,835
0.31% 50
2023
Q3
$986K Hold
1,835
0.5% 48
2023
Q2
$861K Hold
1,835
0.42% 53
2023
Q1
$630K Hold
1,835
0.33% 56
2022
Q4
$671K Hold
1,835
0.27% 60
2022
Q3
$593K Hold
1,835
0.33% 42
2022
Q2
$595K Hold
1,835
0.32% 47
2022
Q1
$525K Buy
1,835
+35
+2% +$9.01K 0.26% 56
2021
Q4
$497K Hold
1,800
0.21% 74
2021
Q3
$416K Sell
1,800
-5
-0.3% -$1.23K 0.18% 80
2021
Q2
$414K Buy
1,805
+5
+0.3% +$1K 0.18% 81
2021
Q1
$336K Hold
1,800
0.15% 85
2020
Q4
$304K Hold
1,800
0.16% 86
2020
Q3
$266K Hold
1,800
0.15% 85
2020
Q2
$296K Hold
1,800
0.16% 74
2020
Q1
$250K Hold
1,800
0.17% 72
2019
Q4
$237K Hold
1,800
0.13% 81
2019
Q3
$201K Buy
+1,800
New +$200K 0.12% 90
2019
Q2
Sell
-1,800
Closed -$234K 93
2019
Q1
$234K Hold
1,800
0.15% 84
2018
Q4
$208K Buy
+1,800
New +$201K 0.14% 89

Other funds holding LLY

Affiance Financial's LLY Position: Q2 2026 in Review

Affiance Financial held its Eli Lilly (LLY) position steady in Q2 2026 at 1,405 shares worth $1.69M. The position accounts for 0.24% of the portfolio, ranked #42.

Affiance Financial first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.74M in Q2 2024. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Affiance Financial held 1,405 shares of Eli Lilly worth $1.69M as of Q2 2026.
  • Affiance Financial left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.24% of Affiance Financial's portfolio in Q2 2026, its #42 holding.
  • Affiance Financial first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Affiance Financial's Eli Lilly position peaked at $1.74M in Q2 2024.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.